Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Evogene (NASDAQ:EVGN) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.
This is a summary of recent ratings and price targets for Kiwa Bio-Tech Products Group and Evogene, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Kiwa Bio-Tech Products Group||0||0||0||0||N/A|
Volatility and Risk
Kiwa Bio-Tech Products Group has a beta of 5.62, suggesting that its share price is 462% more volatile than the S&P 500. Comparatively, Evogene has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.
Institutional and Insider Ownership
35.3% of Evogene shares are owned by institutional investors. 3.5% of Kiwa Bio-Tech Products Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
This table compares Kiwa Bio-Tech Products Group and Evogene’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Kiwa Bio-Tech Products Group||7.33%||23.66%||10.83%|
Earnings and Valuation
This table compares Kiwa Bio-Tech Products Group and Evogene’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Kiwa Bio-Tech Products Group||$17.27 million||0.88||$5.30 million||N/A||N/A|
|Evogene||$3.38 million||17.61||-$20.83 million||N/A||N/A|
Kiwa Bio-Tech Products Group has higher revenue and earnings than Evogene.
Kiwa Bio-Tech Products Group beats Evogene on 7 of the 9 factors compared between the two stocks.
About Kiwa Bio-Tech Products Group
Kiwa Bio-Tech Products Group Corporation, through its subsidiaries, develops, manufactures, distributes, and markets bio-technological products for the agricultural market primarily in the People’s Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic and compound microbial fertilizers. The company has a strategic relationship with ETS (Tianjin) Biological Science and Technology Development Co., Ltd. to produce bio-fertilizers in the People’s Republic of China and internationally; and strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center, as well as China Academy of Agricultural Science’s Institute of Agricultural Resources & Regional Planning, and Institute of Agricultural Economy & Development. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.
Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States, Germany, and internationally. It operates through three segments: Evogene, Evofuel, and Biomica. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. This segment develops seed traits enhancing plant yield and tolerance to abiotic stresses, such as enhanced tolerance to drought, heat, and salinity, as well as seed traits for enhancing plant resistance to biotic stresses, including resistance to diseases, pests, and insects; novel herbicides; and bio-stimulants and bio-pesticides comprising microbial-based products that are applied externally to the plant for yield enhancement. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Evofuel segment develops enhanced species of the castor bean plant to serve as a source of feedstock for biofuel and other industrial uses. The Biomica segment discovers and develops human microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases. The company has strategic collaborations with various agricultural companies, including BASF, Bayer, DuPont, Monsanto, Dow Chemical, Syngenta, Insolo Agroindustrial S.A, and TMG. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Receive News & Ratings for Kiwa Bio-Tech Products Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Kiwa Bio-Tech Products Group and related companies with MarketBeat.com’s FREE daily email newsletter.
- COVID-19 Coronavirus Pandemic
- Samsung launches hand-washing app for Galaxy Watch
- Workers criticize Amazon’s response to protests due to its work with law enforcement
- A $15 toaster and highly rated blender for $30 at Best Buy
- Google faces $5 billion lawsuit for tracking people in incognito mode
- Pokemon Sword and Shield’s first expansion hits Nintendo Switch on June 17
- Zoom won’t add end-to-end encryption to free calls so it can keep aiding police
- Volkswagen Arteon shows off new looks ahead of debut
- Acura Type S badge headed for MDX and ILX replacement, leak suggests